- GlobeNewswire•12 days ago
HAIFA, Israel, Feb. 13, 2017-- Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments for the ...
- Associated Press•16 days ago
On a per-share basis, the Haifa, Israel-based company said it had a loss of 8 cents. The company's shares closed at $1.15. A year ago, they were trading at 80 cents. _____ This story was generated by Automated ...
- GlobeNewswire•last monthPluristem Announces Closing of Bought Offering and Underwriter’s Exercise in Full of Over-Allotment Option
HAIFA, Israel, Jan. 25, 2017-- Pluristem Therapeutics Inc. announced today that H.C. Wainwright & Co., LLC, the sole book-running manager of its previously announced bought offering of 12,244,898 shares ...
PJTA.BE : Summary for PLURISTEM THERAPEUTICS - Yahoo Finance
PLURISTEM THERAPEUTICS (PJTA.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
At close: 5:42PM CET
|Bid||1.06 x 247600|
|Ask||1.08 x 238100|
|Day's Range||1.06 - 1.07|
|52 Week Range||1.03 - 1.58|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|